ETCs counting in combination with SHOX2 and RASSF1A methylation assays in BALF has shown to be highly efficient in lung cancer diagnosis and is an effective complementary tool for clinical diagnosis of lung cancer. This evidence concerns the gene RASSF1 and lung carcinoma.